An announcement from Alterity Therapeutics ( (AU:ATH) ) is now available.

Alterity Therapeutics has scheduled its next Annual General Meeting for 11:00 a.m. AEDT on 20 November 2026, with full meeting details to be circulated to shareholders in a forthcoming Notice of Meeting and posted on the ASX announcements platform and the company’s website. The company has also set 2 October 2026 as the closing date for written director nomination submissions, underscoring upcoming governance decisions that may influence board composition and strategic direction.

These corporate calendar milestones mark an important point for shareholder engagement as Alterity advances its biopharmaceutical programs, providing investors a formal forum to scrutinize management and future plans. The AGM and director nomination window may shape leadership oversight at a time when regulatory compliance and transparent governance are increasingly critical in the life sciences industry.

The most recent analyst rating on (AU:ATH) stock is a Buy
with a A$0.95 price target.
To see the full list of analyst forecasts on Alterity Therapeutics stock,
see the AU:ATH Stock Forecast page.